Insights into wild-type and mutant p53 functions provided by genetically engineered mice

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The TP53 tumor-suppressor gene is the most frequently mutated gene across human cancers.
• Despite extensive research, the precise mechanisms by which TP53 mutations initiate and promote cancer remain incompletely understood.

Purpose of the Study:

• To review insights gained from genetically engineered mouse models with Trp53 mutations.
• To explore how different types of p53 mutations influence cancer development.
• To assess the therapeutic potential of restoring functional p53 signaling in cancer.

Main Methods:

• Utilizing genetically engineered mice with germline or inducible Trp53 somatic mutations.
• Analyzing Trp53 germline mutations affecting specific p53 structural domains or post-translational modification sites.
• Employing genetic approaches to reestablish wild-type p53 function in p53-deficient tissues and tumors.

Main Results:

• Trp53 mutant mouse models have provided critical insights into the role of p53 in cancer initiation and progression.
• Studies on specific p53 mutations in mice have elucidated wild-type p53 functions within a whole organism.
• Restoring p53 function in mouse models demonstrates therapeutic potential for cancer treatment.

Conclusions:

• Genetically engineered Trp53 mouse models are invaluable tools for understanding cancer mechanisms.
• Targeting p53 signaling pathways offers promising therapeutic strategies for various human cancers.